NorthWest Healthcare Properties Real Estate Investment Trust Valuation

Q: What is the Fair Price of NWH.UN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

NWH.UN (CA$5.32) is trading below our estimate of [[fair value]] (CA$5.39)

Is NWH.UN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of NWH.UN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: NWH.UN (CA$5.32) is trading below our estimate of fair value (CA$5.39)

Significantly Below Fair Value: NWH.UN is trading below fair value, but not by a significant amount.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for NWH.UN?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for NWH.UN. This is calculated by dividing NWH.UN's market cap by their current preferred multiple.
What is NWH.UN's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	CA$1.31b

NWH.UN key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	11.4x
Enterprise Value/EBITDA	16.8x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does NWH.UN's PS Ratio compare to its peers?

The above table shows the PS ratio for NWH.UN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	2.9x
MI.UN Minto Apartment Real Estate Investment Trust	4.2x	3.9%	CA$1.1b
PMZ.UN Primaris Real Estate Investment Trust	3x	4.0%	CA$1.4b
MRG.UN Morguard North American Residential Real Estate Investment Trust	1.9x	2.5%	CA$965.2m
HOM.UN BSR Real Estate Investment Trust	2.6x	4.2%	CA$960.3m
NWH.UN NorthWest Healthcare Properties Real Estate Investment Trust	2.5x	-11.0%	CA$1.3b

Price-To-Sales vs Peers: NWH.UN is good value based on its Price-To-Sales Ratio (2.5x) compared to the peer average (2.9x).

Price to Earnings Ratio vs Industry

How does NWH.UN's PE Ratio compare vs other companies in the North American Health Care REITs Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	31.9%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	31.9%
	n/a	n/a	n/a

No more companies

Price-To-Sales vs Industry: NWH.UN is good value based on its Price-To-Sales Ratio (2.5x) compared to the North American Health Care REITs industry average (5.8x).

Price to Sales Ratio vs Fair Ratio

What is NWH.UN's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

NWH.UN PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	2.5x
Fair PS Ratio	2.4x

Price-To-Sales vs Fair Ratio: NWH.UN is expensive based on its Price-To-Sales Ratio (2.5x) compared to the estimated Fair Price-To-Sales Ratio (2.4x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst NWH.UN forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	CA$5.32	CA$5.71 +7.3%	7.3%	CA$6.50	CA$5.25	n/a	6
Aug ’25	CA$4.96	CA$5.75 +15.9%	7.1%	CA$6.50	CA$5.25	n/a	6
Jul ’25	CA$4.66	CA$5.79 +24.3%	6.8%	CA$6.50	CA$5.25	n/a	6
Jun ’25	CA$5.07	CA$5.79 +14.2%	6.8%	CA$6.50	CA$5.25	n/a	6
May ’25	CA$5.05	CA$5.54 +9.7%	9.9%	CA$6.50	CA$5.00	n/a	6
Apr ’25	CA$4.50	CA$5.54 +23.1%	9.9%	CA$6.50	CA$5.00	n/a	6
Mar ’25	CA$4.09	CA$5.54 +35.5%	9.9%	CA$6.50	CA$5.00	n/a	6
Feb ’25	CA$4.89	CA$5.71 +16.7%	8.9%	CA$6.50	CA$5.00	n/a	6
Jan ’25	CA$5.16	CA$5.61 +8.7%	9.5%	CA$6.50	CA$5.00	n/a	7
Dec ’24	CA$4.57	CA$5.61 +22.7%	9.5%	CA$6.50	CA$5.00	n/a	7
Nov ’24	CA$4.20	CA$6.32 +50.5%	10.9%	CA$7.50	CA$5.25	n/a	7
Oct ’24	CA$5.08	CA$6.86 +35.0%	17.7%	CA$9.00	CA$5.50	n/a	7
Sep ’24	CA$6.85	CA$8.36 +22.0%	13.5%	CA$9.50	CA$6.50	n/a	7
Aug ’24	CA$6.82	CA$8.93 +30.9%	17.3%	CA$11.00	CA$6.50	CA$4.96	7
Jul ’24	CA$6.28	CA$9.21 +46.7%	13.2%	CA$11.00	CA$7.00	CA$4.66	7
Jun ’24	CA$7.40	CA$10.50 +41.9%	13.2%	CA$13.00	CA$8.50	CA$5.07	7
May ’24	CA$8.14	CA$10.71 +31.6%	10.8%	CA$13.00	CA$9.00	CA$5.05	7
Apr ’24	CA$8.47	CA$12.14 +43.4%	8.7%	CA$13.50	CA$10.50	CA$4.50	7
Mar ’24	CA$9.40	CA$12.43 +32.2%	10.0%	CA$14.00	CA$10.50	CA$4.09	7
Feb ’24	CA$9.92	CA$12.43 +25.3%	10.0%	CA$14.00	CA$10.50	CA$4.89	7
Jan ’24	CA$9.50	CA$13.11 +38.0%	8.1%	CA$14.00	CA$11.00	CA$5.16	7
Dec ’23	CA$10.11	CA$13.11 +29.6%	8.1%	CA$14.00	CA$11.00	CA$4.57	7
Nov ’23	CA$10.68	CA$14.07 +31.8%	8.5%	CA$15.50	CA$11.50	CA$4.20	7
Oct ’23	CA$10.60	CA$14.50 +36.8%	6.0%	CA$16.00	CA$13.50	CA$5.08	7
Sep ’23	CA$12.31	CA$14.50 +17.8%	6.0%	CA$16.00	CA$13.50	CA$6.85	7
Aug ’23	CA$13.15	CA$14.75 +12.2%	6.4%	CA$16.00	CA$13.50	CA$6.82	7

Analyst Forecast: Target price is less than 20% higher than the current share price.